Clinical Research Directory
Browse clinical research sites, groups, and studies.
Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease
Sponsor: Centre Hospitalier Universitaire de Nice
Summary
The investigator aim to identify the role of inorganic pyrophosphate and other anti-calcifying molecules in vascular disease in children with chronic kidney disease, with a view to developing therapeutic approaches aimed at limiting the onset of vasculopathy.
Official title: Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease - PPi-DIA
Key Details
Gender
All
Age Range
0 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-05-27
Completion Date
2026-11-27
Last Updated
2025-07-10
Healthy Volunteers
No
Interventions
PPI and T50 dosing
Sampling for PPI determination and T50 in blood and urine.
Locations (1)
CHU Nice - Hôpital de l'Archet 2
Nice, Alpes-Maritimes, France